Valeo Pharma Inc.
VPHIF · OTC
10/31/2023 | 10/31/2022 | 10/31/2021 | 10/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$27,808 | -$25,746 | -$14,233 | -$4,761 |
| Dep. & Amort. | $2,626 | $1,418 | $743 | $424 |
| Deferred Tax | $0 | -$1,174 | $530 | $312 |
| Stock-Based Comp. | $870 | $941 | $996 | $469 |
| Change in WC | $4,216 | -$11,484 | -$1,412 | -$2,239 |
| Other Non-Cash | $4,401 | $7,542 | $1,061 | $497 |
| Operating Cash Flow | -$15,695 | -$28,503 | -$12,315 | -$5,298 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$478 | -$6,891 | -$3,465 | -$1,405 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$5,075 | $0 | $0 | $0 |
| Investing Cash Flow | -$5,553 | -$6,891 | -$3,465 | -$1,405 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $2,566 | $19,667 | $3,516 | $1,963 |
| Stock Issued | $3,920 | $394 | $11,500 | $6,900 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$297 | $35,324 | $88 | $344 |
| Financing Cash Flow | $6,189 | $54,991 | $15,104 | $9,207 |
| Forex Effect | $60 | $861 | -$117 | -$3 |
| Net Chg. in Cash | -$14,999 | $20,458 | -$793 | $2,501 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $22,501 | $2,043 | $2,836 | $335 |
| End Cash | $7,502 | $22,501 | $2,043 | $2,836 |
| Free Cash Flow | -$21,248 | -$35,394 | -$15,780 | -$6,703 |